NetworkNewsBreaks – Redfund Capital Corp. (CSE:
Post# of 36

Medical cannabis-focused merchant bank Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) this morning announced the launch of Dr. Klein CBD, a new line of pharma-grade infused CBD nutraceuticals that includes skin topicals and bath products. Per the update, the initial rollout of Dr. Klein CBD will focus on the U.S. chiropractic community and online consumer marketing before rolling out globally in the fall. Redfund also welcomed Dr. Robert Klein as a U.S.-based advisor to the company. “We are pleased to support Dr. Klein and the launch of the Dr. Klein CBD brand of pharma-grade CBD topicals and infused bathing products,” Meris Kott, CEO of Redfund, stated in the news release. “These products will be laboratory tested prior to sales. We look forward to launching the Dr. Klein brand into Europe, South America and into Canada when regulation allows in the fall of 2019. Redfund will have an equity stake in the venture with further details to be released once definitive agreements are signed with Dr. Klein.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

